% Expired Patents = 13.3

CIPO Patents = 2

EPO Patents = 2

Forward Citations = 113

Loading Chart...

4 inventors (with patents filed for the assignee):

Nazli Azimi (15 out of 17 patents)

Yutaka Tagaya (11 out of 13 patents)

Nicholas Doerr (1 out of 1 patent)

4. Laith Q Al-Mawsawi (1 out of 1 patent)

15 patents: Sort by Forward Citations

1. 12600757 - PEPTIDES INHIBITING GAMMA-c-CYTOKINE ACTIVITY AND METHODS OF USE (2026-04-14),

2. 11708392 - Peptide conjugates (2023-07-25),

3. 11462297 - Selective peptide antagonists (2022-10-04),

4. 11400134 - Modulating gamma-c-cytokine activity (2022-08-02),

5. 10854312 - Selective peptide antagonists (2020-12-01),

6. 10808009 - Peptide conjugates (2020-10-20),

7. 10227382 - Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity (2019-03-12),

8. 10030059 - Modulators of gamma-C-cytokine activity (2018-07-24),

9. 10030058 - Modulating gamma-C-cytokine activity (2018-07-24),

10. 9959384 - Methods of developing selective peptide antagonists (2018-05-01),

11. 9951105 - Methods of developing selective peptide antagonists (2018-04-24),

12. 9675672 - Compositions and methods for modulating gamma-C-cytokine activity (2017-06-13),

13. 9133244 - Compositions and methods for modulating gamma-c-cytokine activity (2015-09-15),

14. 9133243 - Compositions and methods for modulating γ-c-cytokine activity (2015-09-15),

15. 8455449 - Compositions and methods for modulating γ-c-cytokine activity (2013-06-04),

Company Overview

Bioniz, LLC is a biotechnology company based in Irvine, California, specializing in the development of innovative therapeutic solutions. The organization focuses on harnessing advanced technologies to create novel treatments that target various medical conditions. With a commitment to research and development, Bioniz aims to improve patient outcomes through its cutting-edge approaches in the field of biomedicine. The company is dedicated to advancing healthcare by leveraging its expertise in biotechnology and therapeutic innovation.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

15 Patents

#211 in Irvine, CA

#5,031 in California

#21,068 in US

#39,959 in the World

Irvine, CA, United States of America

Bioniz, LLC

Forward Citations = 113

4 inventors:

Nazli Azimi (15 out of 17 patents)

Yutaka Tagaya (11 out of 13 patents)

Nicholas Doerr (1 out of 1 patent)

4. Laith Q Al-Mawsawi (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bioniz, LLC. Retrieved from https://idiyas.com/company/bioniz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

2 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]